Prior authorization requirements are a hallmark of American health care — and for some, they’re long overdue for reform. In North Carolina, a bill to restrict prior authorization — or even ...

Prior authorization for medical care was started in the mid-1980s as a marketing scheme by health insurance companies. I know. I was in the room where it happened when I was an officer of the ...

them mentality. In Massachusetts, health plans are required by state law to collaborate with physicians to develop medical necessity guidelines used for prior authorization. With this strong ...

Molina was attracted to ConnectiCare due to the plan’s stable revenue and opportunity to improve margins, according to the CEO. Molina plans to curb medical spending in ConnectiCare’s ...

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of ConnectiCare Holding Company, Inc. (“ConnectiCare”) closed effective as of ...

Molina has closed its $350 million acquisition of ConnectiCare, the health insurer announced Tuesday. The deal adds $1.4 billion in annual premiums to Molina’s topline and 140,000 additional ...

She had no idea the challenges that would lie ahead when her physician submitted the request for prior authorization, or pre-approval from her private insurer. The prior authorization was denied.

(RTTNews) - Molina Healthcare, Inc (MOH), a California-based managed health care company Monday announced that it completed the acquisition of ConnectiCare Holding Company, Inc. as of February 1 ...

Hundreds of people have attended a funeral service for an off-duty police officer who was killed while trying to help at a road crash. Representatives of police forces across the UK gathered in ...

PC Rosie Prior, 45, died when she was hit by a lorry on the A19 in North Yorkshire She had stopped at the scene of a collision on 11 January About 800 people attended PC Prior's funeral at York ...

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...